Literature DB >> 2975913

Dehydroepiandrosterone and structural analogs: a new class of cancer chemopreventive agents.

A G Schwartz1, J M Whitcomb, J W Nyce, M L Lewbart, L L Pashko.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2975913     DOI： 10.1016/s0065-230x(08)60227-4

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN： 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  12 in total

Review 1.  Wishing a dream came true: DHEA as a rejuvenating treatment?

Authors:  O T Wolf; C Kirschbaum
Journal:  J Endocrinol Invest       Date:  1998-02       Impact factor: 4.256

Review 2.  The effects of dehydroepiandrosterone on carcinogenesis, obesity, the immune system, and aging.

Authors:  J R Williams
Journal:  Lipids       Date:  2000-03       Impact factor: 1.880

3.  Effect of short-term exposure of rats to dehydroepiandrosterone on the hepatic metabolism of dimethylnitrosamine.

Authors:  H R Prasanna; R W Hart; P N Magee
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

4.  Dehydroepiandrosterone administration reverses the inhibitory influence of aging on gonadotrophin-releasing hormone gene expression in the male and female rat brain.

Authors:  S Li; L Givalois; G Pelletier
Journal:  Endocrine       Date:  1997-06       Impact factor: 3.633

5.  Dehydroepiandrosterone 3 beta-sulphate is an endogenous activator of the peroxisome-proliferation pathway: induction of cytochrome P-450 4A and acyl-CoA oxidase mRNAs in primary rat hepatocyte culture and inhibitory effects of Ca(2+)-channel blockers.

Authors:  P A Ram; D J Waxman
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

6.  Targeted overexpression of androgen receptor with a liver-specific promoter in transgenic mice.

Authors:  B Chatterjee; C S Song; M H Jung; S Chen; C A Walter; D C Herbert; F J Weaker; M A Mancini; A K Roy
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

7.  Clinicopathological and patient characteristics of early gastric neoplasia endoscopically resected with loss of Mlh1 expression.

Authors:  Shuji Sasaki; Kazuo Yashima; Akihiro Hayashi; Yohei Takeda; Akiko Yasugi; Masaharu Koda; Koichiro Kawaguchi; Kenichi Harada; Hisao Ito; Yoshikazu Murawaki
Journal:  Oncol Lett       Date:  2010-12-30       Impact factor: 2.967

8.  Mechanism of inhibition of growth of 3T3-L1 fibroblasts and their differentiation to adipocytes by dehydroepiandrosterone and related steroids: role of glucose-6-phosphate dehydrogenase.

Authors:  L M Shantz; P Talalay; G B Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

9.  Role of glucose-6-phosphate dehydrogenase inhibition in the antiproliferative effects of dehydroepiandrosterone on human breast cancer cells.

Authors:  M Di Monaco; A Pizzini; V Gatto; L Leonardi; M Gallo; E Brignardello; G Boccuzzi
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Activation of peroxisome proliferator-activated receptors by chlorinated hydrocarbons and endogenous steroids.

Authors:  Y C Zhou; D J Waxman
Journal:  Environ Health Perspect       Date:  1998-08       Impact factor: 9.031
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.